AAAAAA
Results:
1-15
|
Results: 15
Authors:
Zamani, M
Spaepen, M
Sghar, SS
Huang, C
Westerhof, W
Nieuweboer-Krobotova, L
Cassiman, JJ
Citation: M. Zamani et al., Linkage and association of HLA class II genes with vitiligo in a Dutch population, BR J DERM, 145(1), 2001, pp. 90-94
Authors:
Le Poole, IC
Boissy, RE
Sarangarajan, R
Chen, J
Forristal, JJ
Sheth, P
Westerhof, W
Babcock, G
Das, PK
Saelinger, CB
Citation: Ic. Le Poole et al., PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum, IN VITRO-AN, 36(5), 2000, pp. 309-319
Authors:
Westerhof, W
Nieuweboer-Krobotova, L
Verschoor, J
Citation: W. Westerhof et al., Comparison of two occlusive dressings for the treatment of minigraft donorsites in stable vitiligo: a pilot study, J DERM TR, 11(3), 2000, pp. 155-160
Authors:
Njoo, MD
Vodegel, RM
Westerhof, W
Citation: Md. Njoo et al., Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser, J AM ACAD D, 42(5), 2000, pp. 760-769
Authors:
Njoo, MD
Bos, JD
Westerhof, W
Citation: Md. Njoo et al., Treatment of generalized vitiligo in children with narrow-band (TL-01) UVBradiation therapy, J AM ACAD D, 42(2), 2000, pp. 245-253
Authors:
van den Wijngaard, R
Wankowicz-Kalinska, A
Le Poole, C
Tigges, B
Westerhof, W
Das, P
Citation: R. Van Den Wijngaard et al., Local immune response in skin of generalized vitiligo patients - Destruction of melanocytes is associated with the prominent presence of CLA(+) T cells at the perilesional site, LAB INV, 80(8), 2000, pp. 1299-1309
Authors:
Van den Wijngaard, RMJGJ
Aten, J
Scheepmaker, A
Le Poole, IC
Tigges, AJ
Westerhof, W
Das, PK
Citation: Rmjgj. Van Den Wijngaard et al., Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo, BR J DERM, 143(3), 2000, pp. 573-581
Authors:
Njoo, MD
Westerhof, W
Citation: Md. Njoo et W. Westerhof, Guidelines for treatment of vitiligo: Is an update pending if recommendations for children are not followed? In reply, ARCH DERMAT, 136(9), 2000, pp. 1173-1174
Authors:
Njoo, MD
Bossuyt, PMM
Westerhof, W
Citation: Md. Njoo et al., Management of vitiligo. Results of a questionnaire among dermatologists inThe Netherlands, INT J DERM, 38(11), 1999, pp. 866-872
Authors:
Westerhof, W
Nieuweboer-Krobotova, L
Mulder, PGH
Glazenburg, EJ
Citation: W. Westerhof et al., Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo, ARCH DERMAT, 135(9), 1999, pp. 1061-1066
Authors:
Njoo, MD
Das, PK
Bos, JD
Westerhof, W
Citation: Md. Njoo et al., Association of the Kobner phenomenon with disease activity and therapeuticresponsiveness in vitiligo vulgaris, ARCH DERMAT, 135(4), 1999, pp. 407-413
Authors:
Njoo, MD
Westerhof, W
Bos, JD
Bossuyt, PMM
Citation: Md. Njoo et al., The development of guidelines for the treatment of vitiligo, ARCH DERMAT, 135(12), 1999, pp. 1514-1521
Authors:
Das, PK
Van den Wijngaard, MJGJ
Wankowicz-Kalinska, A
Ivanova, K
Westerhof, W
Le Poole, JC
Citation: Pk. Das et al., Human melanocytes in the skin immune system: immunobiology related to vitiligo, IMMUNOLOGY OF THE SKIN AND THE EYE, 1999, pp. 213-231
Authors:
Njoo, MD
Spuls, PI
Bos, JD
Westerhof, W
Bossuyt, PMM
Citation: Md. Njoo et al., Nonsurgical repigmentation therapies in vitiligo - Meta-analysis of the literature, ARCH DERMAT, 134(12), 1998, pp. 1532-1540
Authors:
Njoo, MD
Westerhof, W
Bos, JD
Bossuyt, PMM
Citation: Md. Njoo et al., A systematic review of autologous transplantation methods in vitiligo, ARCH DERMAT, 134(12), 1998, pp. 1543-1549
Risultati:
1-15
|